Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Bluefish Pharmaceuticals AB (publ)

Closing information (x1000 SEK)

Closing information 2025/04 (consolidated) 2024/04 (consolidated) 2023/04 (consolidated)
Turnover 499,380 Less Arrow 484,778 More Arrow 540,097
Financial expenses 32,009 Less Arrow 29,463 More Arrow 41,154
Earnings before taxes 5,253 More Arrow 32,576 Less Arrow -90,170
EBITDA 14,665 More Arrow 47,569 Less Arrow -27,543
Total assets 594,823 Less Arrow 588,902 Less Arrow 540,718
Current assets 455,854 More Arrow 463,129 Less Arrow 411,429
Current liabilities 513,390 Less Arrow 303,608 Less Arrow 202,590
Equity capital 63,725 Less Arrow 44,996 Less Arrow -41,649
- share capital 21,585 Less Arrow 21,584 Equal arrow 21,584
Employees (average) 122 More Arrow 126 More Arrow 128

Financial ratios

Fiscal year 2025/04 (consolidated) 2024/04 (consolidated) 2023/04 (consolidated)
Solvency 10.7% Less Arrow 7.6% Less Arrow -7.7%
Turnover per employee 4,093 Less Arrow 3,847 More Arrow 4,220
Profit as a percentage of turnover 1.1% More Arrow 6.7% Less Arrow -16.7%
Return on assets (ROA) 6.3% More Arrow 10.5% Less Arrow -9.1%
Current ratio 88.8% More Arrow 152.5% More Arrow 203.1%
Return on equity (ROE) 8.2% More Arrow 72.4% More Arrow 216.5%
Change turnover 14,602 Less Arrow -55,319 More Arrow 154,597
Change turnover % 3% Less Arrow -10% More Arrow 40%
Chg. No. of employees -4 More Arrow -2 More Arrow 4
Chg. No. of employees % -3% More Arrow -2% More Arrow 3%

Total value of public sale

Fiscal year 2025/04 (consolidated) 2024/04 (consolidated) 2023/04 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.